Brian Goff | BiotechTV

top of page

Dec 11, 2023

Pyruvate kinase activation as a sickle cell disease strategy with Agios' CEO at #ASH23

Brian Goff highlights data from the phase 2 portion of the RISE UP pivotal study of Mitapivat for SCD that was presented at #ASH23 today.

Agios on today’s phase 2 data for the pyruvate kinase activator mitapivat in sickle cell disease

Jun 26, 2023

Company News

Agios on today’s phase 2 data for the pyruvate kinase activator mitapivat in sickle cell disease

Agios CEO Brian Goff on today's p2 SCD data and how he thinks maitapivat fits into the competitive landscape.

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Klein Hersh is a precision executive search firm with over 25 years of proven success partnering with clients to deliver the visionary leaders shaping the future of life sciences and healthcare. We believe that the innovation behind a healthier world starts with bringing the best and brightest minds together. Our experienced team of dedicated experts is deeply immersed in every facet of pharma, biotech, and healthcare, and has developed trusted relationships with far-reaching talent networks.

Visit Klein Hersh